Novartis Aktie
111,50
EUR
+1,35
EUR
+1,23
%
104,88
CHF
+0,86
CHF
+0,83
%
Werbung
Novartis Aktie Analyse
| 29.03.16 | Novartis Neutral | Citigroup Corp. | |
| 17.02.16 | Novartis Halten | Independent Research GmbH | |
| 28.01.16 | Novartis Hold | S&P Capital IQ | |
| 28.01.16 | Novartis Neutral | BNP PARIBAS | |
| 28.01.16 | Novartis Halten | Independent Research GmbH | |
| 28.01.16 | Novartis Hold | Société Générale Group S.A. (SG) | |
| 13.01.16 | Novartis Halten | Independent Research GmbH | |
| 08.01.16 | Novartis Hold | Deutsche Bank AG | |
|
Werbung
|
|||
| 07.01.16 | Novartis Neutral | Goldman Sachs Group Inc. | |
| 02.12.15 | Novartis Equal-Weight | Morgan Stanley | |
| 30.11.15 | Novartis Hold | Deutsche Bank AG | |
| 25.11.15 | Novartis Neutral | Goldman Sachs Group Inc. | |
| 11.11.15 | Novartis neutral | Morgan Stanley | |
| 28.10.15 | Novartis Halten | Independent Research GmbH | |
| 28.10.15 | Novartis Hold | Deutsche Bank AG | |
| 28.10.15 | Novartis Equal weight | Barclays Capital | |
| 28.10.15 | Novartis Hold | Société Générale Group S.A. (SG) | |
| 27.10.15 | Novartis Hold | S&P Capital IQ | |
| 21.10.15 | Novartis Neutral | Goldman Sachs Group Inc. | |
| 03.09.15 | Novartis Halten | Independent Research GmbH | |
| 27.07.15 | Novartis Neutral | Goldman Sachs Group Inc. | |
| 22.07.15 | Novartis Equal weight | Barclays Capital | |
| 22.07.15 | Novartis Equal-Weight | Morgan Stanley | |
| 21.07.15 | Novartis Hold | S&P Capital IQ | |
| 21.07.15 | Novartis Halten | Independent Research GmbH | |
| 01.07.15 | Novartis neutral | Independent Research GmbH | |
| 05.06.15 | Novartis Neutral | Goldman Sachs Group Inc. | |
| 24.04.15 | Novartis Hold | Deutsche Bank AG | |
| 16.04.15 | Novartis Hold | Société Générale Group S.A. (SG) | |
| 14.04.15 | Novartis neutral | Independent Research GmbH | |
| 01.04.15 | Novartis Equal weight | Barclays Capital | |
| 03.03.15 | Novartis Neutral | Goldman Sachs Group Inc. | |
| 28.01.15 | Novartis neutral | Morgan Stanley | |
| 28.01.15 | Novartis Hold | Deutsche Bank AG | |
| 27.01.15 | Novartis Halten | Independent Research GmbH | |
| 26.01.15 | Novartis Neutral | Goldman Sachs Group Inc. | |
| 21.01.15 | Novartis neutral | Morgan Stanley | |
| 20.01.15 | Novartis Equal-Weight | Morgan Stanley | |
| 20.01.15 | Novartis neutral | Independent Research GmbH | |
| 16.01.15 | Novartis Neutral | Goldman Sachs Group Inc. | |
| 15.01.15 | Novartis Hold | Deutsche Bank AG | |
| 15.12.14 | Novartis Neutral | Goldman Sachs Group Inc. | |
| 09.12.14 | Novartis Neutral | Merrill Lynch & Co., Inc. | |
| 09.12.14 | Novartis Neutral | Merrill Lynch & Co., Inc. | |
| 03.12.14 | Novartis Equal-Weight | Morgan Stanley | |
| 31.10.14 | Novartis Halten | Independent Research GmbH | |
| 29.10.14 | Novartis Hold | Deutsche Bank AG | |
| 16.10.14 | Novartis Equal weight | Barclays Capital | |
| 08.10.14 | Novartis Hold | Deutsche Bank AG | |
| 19.09.14 | Novartis Hold | Deutsche Bank AG | |
Werbung
Werbung